{"transactions":[{"id":1213267,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Restricted Stock Units","published_at":"2025-03-11T20:34:48.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":28890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":28890,"derivative":{"exercise_price":0,"exercise_date":"2024-03-07","expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":28890},"source":{"system":"sec-edgar","filing":"0001593968-25-000333","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000333/primary_01.xml","form_type":"4"}},{"id":1213266,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-11T20:34:48.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":13954,"price":8.34,"value":116376.36,"ownership":{"direct":true},"balance_after":68061,"source":{"system":"sec-edgar","filing":"0001593968-25-000333","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000333/primary_01.xml","form_type":"4"}},{"id":1213265,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-11T20:34:48.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":28890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":82015,"source":{"system":"sec-edgar","filing":"0001593968-25-000333","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000333/primary_01.xml","form_type":"4"}},{"id":1231759,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:47:09.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":96000,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001593968-25-000289","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000289/primary_01.xml","form_type":"4"}},{"id":1231758,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-04T23:47:09.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":23185,"price":8.33,"value":193131.05,"ownership":{"direct":true},"balance_after":53125,"source":{"system":"sec-edgar","filing":"0001593968-25-000289","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000289/primary_01.xml","form_type":"4"}},{"id":1231757,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-03-04T23:47:09.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76310,"source":{"system":"sec-edgar","filing":"0001593968-25-000289","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000289/primary_01.xml","form_type":"4"}},{"id":1426857,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2024-08-21T20:47:46.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-08-19","underlying":"Common Stock","underlying_shares":655},"source":{"system":"sec-edgar","filing":"0001593968-24-001090","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001090/primary_01.xml","form_type":"4"}},{"id":1426856,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2024-08-21T20:47:46.000Z","date":"2024-08-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":317,"price":13.9,"value":4406.3,"ownership":{"direct":true},"balance_after":28310,"source":{"system":"sec-edgar","filing":"0001593968-24-001090","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001090/primary_01.xml","form_type":"4"}},{"id":1426855,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"officer":true,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2024-08-21T20:47:46.000Z","date":"2024-08-19","kind":"exercise","planned":false,"acquired":true,"shares":655,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28627,"source":{"system":"sec-edgar","filing":"0001593968-24-001090","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001090/primary_01.xml","form_type":"4"}},{"id":1561112,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T23:03:07.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":144000,"derivative":{"underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-24-039169","document":"tm249879-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039169/tm249879-6_4seq1.xml","form_type":"4"}},{"id":1582178,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Restricted Stock Units","published_at":"2024-03-13T00:45:15.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":4608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 10, 2022, the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 10, 2022, the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":4608,"derivative":{"underlying":"Common Stock","underlying_shares":4608},"source":{"system":"sec-edgar","filing":"0001104659-24-033619","document":"tm248710-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033619/tm248710-1_4seq1.xml","form_type":"4"}},{"id":1582177,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-13T00:45:15.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2226,"price":5.45,"value":12131.7,"ownership":{"direct":true},"balance_after":27972,"source":{"system":"sec-edgar","filing":"0001104659-24-033619","document":"tm248710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033619/tm248710-1_4seq1.xml","form_type":"4"}},{"id":1582176,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-13T00:45:15.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":4608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":30198,"source":{"system":"sec-edgar","filing":"0001104659-24-033619","document":"tm248710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033619/tm248710-1_4seq1.xml","form_type":"4"}},{"id":1585000,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T01:40:13.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":false,"shares":28890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":57780},"source":{"system":"sec-edgar","filing":"0001104659-24-033164","document":"tm248549-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033164/tm248549-2_4seq1.xml","form_type":"4"}},{"id":1584999,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2024-03-12T01:40:13.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":13955,"price":5.61,"value":78287.55,"ownership":{"direct":true},"balance_after":25590,"source":{"system":"sec-edgar","filing":"0001104659-24-033164","document":"tm248549-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033164/tm248549-2_4seq1.xml","form_type":"4"}},{"id":1584998,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2024-03-12T01:40:13.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":true,"shares":28890,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":39545,"source":{"system":"sec-edgar","filing":"0001104659-24-033164","document":"tm248549-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033164/tm248549-2_4seq1.xml","form_type":"4"}},{"id":1708022,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2023-12-18T22:12:26.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSU\"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units (\"RSU\"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001209191-23-058990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058990/doc4.xml","form_type":"4"}},{"id":1708021,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-12-18T22:12:26.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":773,"price":5.69,"value":4398.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":10655,"source":{"system":"sec-edgar","filing":"0001209191-23-058990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058990/doc4.xml","form_type":"4"}},{"id":1708020,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-12-18T22:12:26.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (\"RSU\"s) subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":11428,"source":{"system":"sec-edgar","filing":"0001209191-23-058990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058990/doc4.xml","form_type":"4"}},{"id":1800013,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2023-08-22T20:47:08.000Z","date":"2023-08-19","kind":"exercise","planned":false,"acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 19, 2021 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 19, 2021 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":655,"derivative":{"underlying":"Common Stock","underlying_shares":655},"source":{"system":"sec-edgar","filing":"0001209191-23-046915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046915/doc4.xml","form_type":"4"}},{"id":1800012,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-08-22T20:47:08.000Z","date":"2023-08-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":317,"price":7.14,"value":2263.38,"ownership":{"direct":true},"balance_after":9828,"source":{"system":"sec-edgar","filing":"0001209191-23-046915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046915/doc4.xml","form_type":"4"}},{"id":1800011,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-08-22T20:47:08.000Z","date":"2023-08-19","kind":"exercise","planned":false,"acquired":true,"shares":655,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":10145,"source":{"system":"sec-edgar","filing":"0001209191-23-046915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046915/doc4.xml","form_type":"4"}},{"id":1843720,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2023-06-27T20:32:40.000Z","date":"2023-06-25","kind":"exercise","planned":false,"acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001209191-23-039891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123039891/doc4.xml","form_type":"4"}},{"id":1843719,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-06-27T20:32:40.000Z","date":"2023-06-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":403,"price":6.7,"value":2700.1,"ownership":{"direct":true},"balance_after":9490,"source":{"system":"sec-edgar","filing":"0001209191-23-039891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123039891/doc4.xml","form_type":"4"}},{"id":1843718,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-06-27T20:32:40.000Z","date":"2023-06-25","kind":"exercise","planned":false,"acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":9893,"source":{"system":"sec-edgar","filing":"0001209191-23-039891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123039891/doc4.xml","form_type":"4"}},{"id":1955188,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:20:14.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":4609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":9216,"derivative":{"underlying":"Common Stock","underlying_shares":4609},"source":{"system":"sec-edgar","filing":"0001209191-23-018553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018553/doc4.xml","form_type":"4"}},{"id":1955187,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-03-14T21:20:14.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":2471,"price":6.52,"value":16110.92,"ownership":{"direct":true},"balance_after":9060,"source":{"system":"sec-edgar","filing":"0001209191-23-018553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018553/doc4.xml","form_type":"4"}},{"id":1955186,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2023-03-14T21:20:14.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":4609,"price":6.52,"value":30050.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the reporting person in connection with vesting of restricted stock units (\"RSUs\")."}],"balance_after":11531,"source":{"system":"sec-edgar","filing":"0001209191-23-018553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018553/doc4.xml","form_type":"4"}},{"id":1961631,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2023-03-09T22:02:08.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":86670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":86670,"derivative":{"underlying":"Common Stock","underlying_shares":86670},"source":{"system":"sec-edgar","filing":"0001209191-23-017586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123017586/doc4.xml","form_type":"4"}},{"id":1961630,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T22:02:08.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 7, 2023 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":100100,"derivative":{"exercise_price":6.97,"exercise_date":"2024-03-07","expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":100100},"source":{"system":"sec-edgar","filing":"0001209191-23-017586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123017586/doc4.xml","form_type":"4"}},{"id":2084262,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2022-12-16T22:03:48.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":1600,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001209191-22-061707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061707/doc4.xml","form_type":"4"}},{"id":2084261,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-12-16T22:03:48.000Z","date":"2022-12-14","kind":"tax_withholding","acquired":false,"shares":773,"price":17.23,"value":13318.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022."}],"balance_after":6922,"source":{"system":"sec-edgar","filing":"0001209191-22-061707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061707/doc4.xml","form_type":"4"}},{"id":2084260,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-12-16T22:03:48.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the Reporting Person in connection with vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":7695,"source":{"system":"sec-edgar","filing":"0001209191-22-061707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122061707/doc4.xml","form_type":"4"}},{"id":2150111,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2022-09-28T21:04:22.000Z","date":"2022-09-26","kind":"exercise","acquired":false,"shares":3538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3538},"source":{"system":"sec-edgar","filing":"0001209191-22-051474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051474/doc4.xml","form_type":"4"}},{"id":2150110,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-09-28T21:04:22.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":1709,"price":18.87,"value":32248.83,"ownership":{"direct":true},"balance_after":6095,"source":{"system":"sec-edgar","filing":"0001209191-22-051474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051474/doc4.xml","form_type":"4"}},{"id":2150109,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-09-28T21:04:22.000Z","date":"2022-09-26","kind":"exercise","acquired":true,"shares":3538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":7804,"source":{"system":"sec-edgar","filing":"0001209191-22-051474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122051474/doc4.xml","form_type":"4"}},{"id":2176417,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2022-08-23T21:03:39.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 19, 2021 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 19, 2021 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":1310,"derivative":{"underlying":"Common Stock","underlying_shares":655},"source":{"system":"sec-edgar","filing":"0001209191-22-047212","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122047212/doc4.xml","form_type":"4"}},{"id":2176416,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-08-23T21:03:39.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":317,"price":36.22,"value":11481.74,"ownership":{"direct":true},"balance_after":4266,"source":{"system":"sec-edgar","filing":"0001209191-22-047212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122047212/doc4.xml","form_type":"4"}},{"id":2176415,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-08-23T21:03:39.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":655,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":4583,"source":{"system":"sec-edgar","filing":"0001209191-22-047212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122047212/doc4.xml","form_type":"4"}},{"id":2220481,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2022-06-28T21:06:35.000Z","date":"2022-06-25","kind":"exercise","acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":833,"derivative":{"underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001209191-22-039639","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122039639/doc4.xml","form_type":"4"}},{"id":2220480,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-06-28T21:06:35.000Z","date":"2022-06-25","kind":"tax_withholding","acquired":false,"shares":278,"price":51.67,"value":14364.26,"ownership":{"direct":true},"balance_after":3928,"source":{"system":"sec-edgar","filing":"0001209191-22-039639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122039639/doc4.xml","form_type":"4"}},{"id":2220479,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2022-06-28T21:06:35.000Z","date":"2022-06-25","kind":"exercise","acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":4206,"source":{"system":"sec-edgar","filing":"0001209191-22-039639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122039639/doc4.xml","form_type":"4"}},{"id":2336264,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T23:51:00.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":13825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":13825,"derivative":{"underlying":"Common Stock","underlying_shares":13825},"source":{"system":"sec-edgar","filing":"0001209191-22-018660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018660/doc4.xml","form_type":"4"}},{"id":2336263,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T23:51:00.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":20737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 10, 2022 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":20737,"derivative":{"exercise_price":77.77,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":20737},"source":{"system":"sec-edgar","filing":"0001209191-22-018660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018660/doc4.xml","form_type":"4"}},{"id":2470478,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2021-12-16T22:18:54.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":3200,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001209191-21-070021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070021/doc4.xml","form_type":"4"}},{"id":2470477,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-12-16T22:18:54.000Z","date":"2021-12-14","kind":"tax_withholding","acquired":false,"shares":773,"price":168.43,"value":130196.39,"ownership":{"direct":true},"balance_after":3373,"source":{"system":"sec-edgar","filing":"0001209191-21-070021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070021/doc4.xml","form_type":"4"}},{"id":2470476,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-12-16T22:18:54.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":4146,"source":{"system":"sec-edgar","filing":"0001209191-21-070021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121070021/doc4.xml","form_type":"4"}},{"id":2557021,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"exercise","acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"On April 17, 2020, the reporting person was granted an option to purchase 140,000 shares of common stock of Novavax, Inc. (the \"Company\") pursuant to the Company's Amended and Restated 2015 Stock Incentive Plan, as amended. The vesting of the shares subject to this option grant is subject to the satisfaction of a performance-based vesting requirement, followed by time-based vesting. The performance metric required that the Company initiate a COVID-19 Phase 2 clinical trial within twelve (12) months of the grant date, which occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020. Following that event, fifty percent (50%) of the shares vested on August 24, 2021, the first anniversary of the initiation date, and the remaining fifty percent (50%) of the shares will vest on August 24, 2022, the second anniversary of the initiation date subject to continued employment through such vesting date."}],"balance_after":95000,"derivative":{"exercise_price":19.08,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557020,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":156,"price":229.9977,"value":35879.6412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.94 to $230.03, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":2546,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557019,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":323,"price":228.2517,"value":73725.2991,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.19 to $228.42, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":2702,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557018,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":148,"price":224.2398,"value":33187.4904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.02 to $224.80, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3025,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557017,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":255,"price":222.8629,"value":56830.0395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.20 to $222.98, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3173,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557016,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":49,"price":220.2218,"value":10790.8682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.21 to $220.23, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3428,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557015,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":421,"price":219.2639,"value":92310.1019,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.95 to $219.50, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3477,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557014,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":226,"price":218.1284,"value":49297.0184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.87 to $218.65, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3898,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557013,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":247,"price":216.2094,"value":53403.7218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.85 to $216.51, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4124,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557012,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":318,"price":214.6475,"value":68257.905,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.41 to $215.01, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4371,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557011,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":30,"price":213.11,"value":6393.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4689,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557010,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":100,"price":211.45,"value":21145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":4719,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557009,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":112,"price":209.57,"value":23471.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.29 to $209.85, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4819,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557008,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":312,"price":208.4567,"value":65038.4904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.14 to $208.82, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4931,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557007,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":382,"price":207.319,"value":79195.858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.94 to $207.75, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":5243,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557006,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":990,"price":206.3028,"value":204239.772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.84 to $206.82, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557005,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":1452,"price":205.2541,"value":298028.9532,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.83 to $205.80, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":6615,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557004,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":1141,"price":204.123,"value":232904.343,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.73 to $204.71, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":8067,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557003,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":839,"price":203.2628,"value":170537.4892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.69 to $203.58, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":9208,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557002,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:06:29.000Z","date":"2021-09-28","kind":"exercise","acquired":true,"shares":7501,"price":19.08,"value":143119.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":10047,"source":{"system":"sec-edgar","filing":"0001209191-21-058075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058075/doc4.xml","form_type":"4"}},{"id":2557001,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"exercise","acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"On April 17, 2020, the reporting person was granted an option to purchase 140,000 shares of common stock of Novavax, Inc. (the \"Company\") pursuant to the Company's Amended and Restated 2015 Stock Incentive Plan, as amended. The vesting of the shares subject to this option grant is subject to the satisfaction of a performance-based vesting requirement, followed by time-based vesting. The performance metric required that the Company initiate a COVID-19 Phase 2 clinical trial within twelve (12) months of the grant date, which occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020. Following that event, fifty percent (50%) of the shares vested on August 24, 2021, the first anniversary of the initiation date, and the remaining fifty percent (50%) of the shares will vest on August 24, 2022, the second anniversary of the initiation date subject to continued employment through such vesting date."}],"balance_after":102501,"derivative":{"exercise_price":19.08,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2557000,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":70,"price":249.04,"value":17432.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2546,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556999,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":297,"price":248.1569,"value":73702.5993,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.00 to $248.55, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":2616,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556998,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":100,"price":246.49,"value":24649.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2913,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556997,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":212,"price":244.9924,"value":51938.3888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.97 to $245.00, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3013,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556996,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":53,"price":243.2021,"value":12889.7113,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.19 to $243.21, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3225,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556995,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":114,"price":240.6,"value":27428.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.25 to $240.95, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3278,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556994,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":569,"price":239.714,"value":136397.266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.15 to $240.10, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3392,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556993,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":100,"price":237.58,"value":23758.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":3961,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556992,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":267,"price":236.7451,"value":63210.9417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.52 to $237.17, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4061,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556991,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":369,"price":235.7704,"value":86999.2776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $236.10, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4328,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556990,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":849,"price":234.3748,"value":198984.2052,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.11 to $234.92, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4697,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556989,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":1270,"price":233.2479,"value":296224.833,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.76 to $233.73, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":5546,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556988,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":924,"price":231.9506,"value":214322.3544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.60 to $232.52, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":6816,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556987,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":1365,"price":231.1575,"value":315529.9875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.59 to $231.58, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":7740,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556986,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":628,"price":230.1874,"value":144557.6872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.50 to $230.47, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":9105,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556985,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":314,"price":228.6862,"value":71807.4668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.22 to $229.06, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":9733,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2556984,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-29T21:04:36.000Z","date":"2021-09-27","kind":"exercise","acquired":true,"shares":7501,"price":19.08,"value":143119.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":10047,"source":{"system":"sec-edgar","filing":"0001209191-21-058074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121058074/doc4.xml","form_type":"4"}},{"id":2558088,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Restricted Stock Units","published_at":"2021-09-28T21:06:42.000Z","date":"2021-09-26","kind":"exercise","acquired":false,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":3538,"derivative":{"underlying":"Common Stock","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001209191-21-057942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057942/doc4.xml","form_type":"4"}},{"id":2558087,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-28T21:06:42.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":1709,"price":248.16,"value":424105.44,"ownership":{"direct":true},"balance_after":2546,"source":{"system":"sec-edgar","filing":"0001209191-21-057942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057942/doc4.xml","form_type":"4"}},{"id":2558086,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-28T21:06:42.000Z","date":"2021-09-26","kind":"exercise","acquired":true,"shares":3537,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":4255,"source":{"system":"sec-edgar","filing":"0001209191-21-057942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057942/doc4.xml","form_type":"4"}},{"id":2562391,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"On April 17, 2020, the reporting person was granted an option to purchase 140,000 shares of common stock of Novavax, Inc. (the \"Company\") pursuant to the Company's Amended and Restated 2015 Stock Incentive Plan, as amended. The vesting of the shares subject to this option grant is subject to the satisfaction of a performance-based vesting requirement, followed by time-based vesting. The performance metric required that the Company initiate a COVID-19 Phase 2 clinical trial within twelve (12) months of the grant date, which occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020. Following that event, fifty percent (50%) of the shares vested on August 24, 2021, the first anniversary of the initiation date, and the remaining fifty percent (50%) of the shares will vest on August 24, 2022, the second anniversary of the initiation date subject to continued employment through such vesting date."}],"balance_after":110002,"derivative":{"exercise_price":19.08,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562390,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-20","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F20","text":"On April 17, 2020, the reporting person was granted an option to purchase 140,000 shares of common stock of Novavax, Inc. (the \"Company\") pursuant to the Company's Amended and Restated 2015 Stock Incentive Plan, as amended. The vesting of the shares subject to this option grant is subject to the satisfaction of a performance-based vesting requirement, followed by time-based vesting. The performance metric required that the Company initiate a COVID-19 Phase 2 clinical trial within twelve (12) months of the grant date, which occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020. Following that event, fifty percent (50%) of the shares vested on August 24, 2021, the first anniversary of the initiation date, and the remaining fifty percent (50%) of the shares will vest on August 24, 2022, the second anniversary of the initiation date subject to continued employment through such vesting date."}],"balance_after":117502,"derivative":{"exercise_price":19.08,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562389,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":368,"price":231.1134,"value":85049.7312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.81 to $231.49, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":718,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562388,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":1515,"price":230.3121,"value":348922.8315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.76 to $230.71, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":1086,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562387,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":726,"price":229.0327,"value":166277.7402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.73 to $229.34, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":2601,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562386,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":853,"price":228.2222,"value":194673.5366,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.63 to $228.50, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":3327,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562385,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":585,"price":227.0854,"value":132844.959,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.60 to $227.55, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562384,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":1365,"price":226.2425,"value":308821.0125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.59 to $226.56, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":4765,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562383,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":1269,"price":224.7929,"value":285262.1901,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.31 to $225.29, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":6130,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562382,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":819,"price":223.947,"value":183412.593,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.31 to $224.30, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":7399,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562381,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-21","kind":"exercise","acquired":true,"shares":7500,"price":19.08,"value":143100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":8218,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}},{"id":2562380,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":82169,"kind":"person","name":"Trizzino John","position":1,"cik":"0001468534","reported_name":"Trizzino John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CCO and CBO"}}],"security":"Common Stock","published_at":"2021-09-22T21:05:51.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":112,"price":232.895,"value":26084.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.82 to $232.97, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":718,"source":{"system":"sec-edgar","filing":"0001209191-21-057280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121057280/doc4.xml","form_type":"4"}}],"next_cursor":"2021-09-22T21:05:51.000000Z,2562380"}